Floatz logo

249 assets in Head And Neck Squamous Cell Carcinoma

Therapeutic assets addressing Head And Neck Squamous Cell Carcinoma, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Immunoglobulin G1-Kappa, Anti-[Homo Sapiens Klrb1 (Killer Cell Lectin Like Receptor B1, Nkr-P1A, Natural Killer Cell Surface Protein P1A, Clec5B, Cd161)], Homo Sapiens Monoclonal Antibody; Gamma1 Heavy Chain Homo Sapiens (1-450) [Vh (Homo Sapiens Ighv3-23*01 (96.9%) -(Ighd) -Ighj4*01 (85.7%), Q120>R (113), Cdr-Imgt [8.8.14] (26-33.51-58.97-110)) (1-121) -Homo Sapiens Ighg1*01, G1M17,1 Ch1 K120, Ch3 D12, L14, G1V29 Ch2 A84.4 (Ch1 K120 (218) (122-219), Hinge 1-15 (220-234), Ch2 G1V29 Ch2 N84.4>A (301) (235-344), Ch3 D12 (360), L14 (362) (345-449), Chs K2>Del (450)) (122-450)], (224-214')-Disulfide With Kappa Light Chain Homo Sapiens (1'-214') [V-Kappa (Homo Sapiens Igkv1-12*01 (94.7%) -Igkj4*01 (91.7%), Cdr-Imgt [6.3.9] (27'-32'.50'-52'.89'-97')) (1'-107') -Homo Sapiens Igkc*01 (100%), Km3, A45.1 (153'), V101 (191') (108'-214')]; Dimer (230-230'':233-233'')-Bisdisulfide, Produced In Chinese Hamster Ovary (Cho) Cells, Cell Line Cho-K1 Lacking The Glutamine Synthetase (Gs-Ko) Gene, Non-Glycosylated
Head And Neck Squamous Cell Carcinoma
Immunitas TherapeuticsP1/2CC (41)
Immunoglobulin G1-Kappa, Anti-[Homo Sapiens Met (Met Proto-Oncogene, Hepatocyte Growth Factor (Hgf) Receptor, Hgfr, Scatter Factor (Sf) Receptor, Hgf/Sf Receptor, Receptor Tyrosine-Protein Kinase C-Met, Papillary Renal Cell Carcinoma 2, Rccp2)] And Anti-[Homo Sapiens Egfr (Epidermal Growth Factor Receptor, Receptor Tyrosine-Protein Kinase Erbb-1, Erbb1, Her1, Her-1, Erbb)], Homo Sapiens Monoclonal Antibody, Bispecific
Head And Neck Squamous Cell Carcinoma
Merus B.V.P1/2CC (41)
ipn01194
Head And Neck Squamous Cell Carcinoma
IpsenP1/2CC (41)
kfa115
Head And Neck Squamous Cell Carcinoma
Novartis PharmaceuticalsP1CC (41)
MGC026
Head And Neck Squamous Cell Carcinoma
MacroGenicsP1CC (41)
Monoclonal Antibody Neo-201
Head And Neck Squamous Cell Carcinoma
Precision Biologics, IncP1/2CC (41)
mt-8421
Head And Neck Squamous Cell Carcinoma
Molecular Templates, Inc.P1CC (41)
Nadravaleucel
Head And Neck Squamous Cell Carcinoma
NKGen Biotech, Inc.P1/2CC (41)
neo212
Head And Neck Squamous Cell Carcinoma
Neonc Technologies, Inc.P1/2CC (41)
ngm438
Head And Neck Squamous Cell Carcinoma
NGM Biopharmaceuticals, IncP1CC (41)
ngm831
Head And Neck Squamous Cell Carcinoma
NGM Biopharmaceuticals, IncP1CC (41)
Nrm-823
Head And Neck Squamous Cell Carcinoma
Normunity AccelCo, Inc.P1CC (41)
okn4395
Head And Neck Squamous Cell Carcinoma
EpkinP1CC (41)
Osimertinib
Head And Neck Squamous Cell Carcinoma
Merus B.V.P1/2CC (41)
Panda-Vac
Head And Neck Squamous Cell Carcinoma
UNC Lineberger Comprehensive Cancer CenterP1CC (41)
Pexmetinib
Head And Neck Squamous Cell Carcinoma
Dan ZandbergP1/2CC (41)
qeq278
Head And Neck Squamous Cell Carcinoma
Novartis PharmaceuticalsP1CC (41)
Rilvegostomig
Head And Neck Squamous Cell Carcinoma
AstraZenecaP1/2CC (41)
Rtx-224
Head And Neck Squamous Cell Carcinoma
Rubius TherapeuticsP1/2CC (41)
Sacituzumab Tirumotecan
Head And Neck Squamous Cell Carcinoma
Klus Pharma Inc.P1/2CC (41)
Spx-303
Head And Neck Squamous Cell Carcinoma
SparX Biotech(Jiangsu) Co., Ltd.P1CC (41)
SX682
Head And Neck Squamous Cell Carcinoma
National Cancer Institute (NCI)P1/2CC (41)
Ter-2013
Head And Neck Squamous Cell Carcinoma
Terremoto Biosciences Inc.P1/2CC (41)
tt-10
Head And Neck Squamous Cell Carcinoma
Portage BiotechP1/2CC (41)
tt-4
Head And Neck Squamous Cell Carcinoma
Portage BiotechP1/2CC (41)
tu2218
Head And Neck Squamous Cell Carcinoma
TiumBio Co., Ltd.P1/2CC (41)
Valemetostat
Head And Neck Squamous Cell Carcinoma
National Cancer Institute (NCI)P1/2CC (41)
Vls-1488
Head And Neck Squamous Cell Carcinoma
Volastra Therapeutics, Inc.P1/2CC (41)
Vofatamab
Head And Neck Squamous Cell Carcinoma
Fusion Pharmaceuticals Inc.P1/2CC (41)
Wu-Nk-101
Head And Neck Squamous Cell Carcinoma
Wugen, Inc.P1CC (41)
Zanzalintinib
Head And Neck Squamous Cell Carcinoma
ExelixisP1CC (41)
Zovostotug
Head And Neck Squamous Cell Carcinoma
OncoResponse, Inc.P1/2CC (41)
prt3645
Head And Neck Squamous Cell Carcinoma
Prelude TherapeuticsP1CC (40)
Vobramitamab Duocarmazine
Head And Neck Squamous Cell Carcinoma
MacroGenicsP2CC (40)
Xmab808
Head And Neck Squamous Cell Carcinoma
Xencor, Inc.P1CC (40)
177lu-rad204
Head And Neck Squamous Cell Carcinoma
Radiopharm Theranostics, LtdEarly P1C (38)
[111in]-fpi-2107
Head And Neck Squamous Cell Carcinoma
AstraZenecaP1C (37)
1H-Isoindol-1-one, 2,3-dihydro-2-[3-[cis-3-methyl-1-(4-methyl-4H-1,2,4-triazol-3-yl)cyclobutyl]phenyl]-6-[[(3S)-3-methyl-1-piperidinyl]methyl]-4-(trifluoromethyl)-
Head And Neck Squamous Cell Carcinoma
Nurix Therapeutics, Inc.P1C (37)
[225ac]-fpi-2068
Head And Neck Squamous Cell Carcinoma
AstraZenecaP1C (37)
ai-061
Head And Neck Squamous Cell Carcinoma
OncoC4, Inc.P1C (37)
Autologous Anti-Cd19 Car-Expressing T Lymphocytes
Head And Neck Squamous Cell Carcinoma
Anusha KalbasiP1C (37)
Autologous, Engineered T Cells Targeting Tp53 R175H
Head And Neck Squamous Cell Carcinoma
AstraZenecaP1C (37)
Azirkitug
Head And Neck Squamous Cell Carcinoma
AbbVieP1C (37)
Bl-M24D1
Head And Neck Squamous Cell Carcinoma
Sichuan Baili Pharmaceutical Co., Ltd.P1C (37)
Budigalimab
Head And Neck Squamous Cell Carcinoma
AbbVieP1C (37)
Cadvec
Head And Neck Squamous Cell Carcinoma
Baylor College of MedicineP1C (37)
cht101
Head And Neck Squamous Cell Carcinoma
Zhejiang UniversityP1C (37)
Clsp-1025
Head And Neck Squamous Cell Carcinoma
Clasp Therapeutics, Inc.P1C (37)
Ctx-8371
Head And Neck Squamous Cell Carcinoma
Compass TherapeuticsP1C (37)
Drug: Ibi3028
Head And Neck Squamous Cell Carcinoma
Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD.P1C (37)
Showing 151 to 200 of 249 assets
PreviousPage 4 of 5Next